Trivarx Ltd has released a press release.
Medibio enters agreement with Mayo Clinc
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Medibio initiates confirmatory study
- Medibio announces positive clinical study results
- Quarterly ASX Update and Cashflows
- Scientific breakthrough on objective diagnosis of PTSD
- Independent researchers present first data validating MEB
Later from TrivarX
- Medibio enters into an Agreement with Otsuka Pharmaceutical
- Response to ASX Query
- MEB completes heavily oversubscribed institutional placement
- Appendix 4C - quarterly
- Medibio & Mayo Clinic collaborate on depression technology
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX